268 related articles for article (PubMed ID: 35897789)
1. Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression.
Yamashita N; Kufe D
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897789
[TBL] [Abstract][Full Text] [Related]
2. MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Yamashita N; Morimoto Y; Fushimi A; Ahmad R; Bhattacharya A; Daimon T; Haratake N; Inoue Y; Ishikawa S; Yamamoto M; Hata T; Akiyoshi S; Hu Q; Liu T; Withers H; Liu S; Shapiro GI; Yoshizumi T; Long MD; Kufe D
Mol Cancer Res; 2023 Mar; 21(3):274-289. PubMed ID: 36445328
[TBL] [Abstract][Full Text] [Related]
3. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Yamashita N; Long M; Fushimi A; Yamamoto M; Hata T; Hagiwara M; Bhattacharya A; Hu Q; Wong KK; Liu S; Kufe D
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495298
[TBL] [Abstract][Full Text] [Related]
4. Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.
Hata T; Rajabi H; Yamamoto M; Jin C; Ahmad R; Zhang Y; Kui L; Li W; Yasumizu Y; Hong D; Miyo M; Hiraki M; Maeda T; Suzuki Y; Takahashi H; Samur M; Kufe D
Mol Cancer Ther; 2019 Oct; 18(10):1744-1754. PubMed ID: 31308076
[TBL] [Abstract][Full Text] [Related]
5. MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells.
Bhattacharya A; Fushimi A; Yamashita N; Hagiwara M; Morimoto Y; Rajabi H; Long MD; Abdulla M; Ahmad R; Street K; Liu S; Liu T; Kufe D
Mol Cancer Res; 2022 Apr; 20(4):556-567. PubMed ID: 35022313
[TBL] [Abstract][Full Text] [Related]
6. Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer.
Kufe D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835130
[TBL] [Abstract][Full Text] [Related]
7. MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer.
Maeda T; Hiraki M; Jin C; Rajabi H; Tagde A; Alam M; Bouillez A; Hu X; Suzuki Y; Miyo M; Hata T; Hinohara K; Kufe D
Cancer Res; 2018 Jan; 78(1):205-215. PubMed ID: 29263152
[TBL] [Abstract][Full Text] [Related]
8. MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells.
Yamamoto M; Jin C; Hata T; Yasumizu Y; Zhang Y; Hong D; Maeda T; Miyo M; Hiraki M; Suzuki Y; Hinohara K; Rajabi H; Kufe D
Cancer Res; 2019 Apr; 79(8):2031-2041. PubMed ID: 30824588
[TBL] [Abstract][Full Text] [Related]
9. Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells.
Teslow EA; Mitrea C; Bao B; Mohammad RM; Polin LA; Dyson G; Purrington KS; Bollig-Fischer A
Mol Oncol; 2019 Apr; 13(4):894-908. PubMed ID: 30636104
[TBL] [Abstract][Full Text] [Related]
10. MUC1-C drives stemness in progression of colitis to colorectal cancer.
Li W; Zhang N; Jin C; Long MD; Rajabi H; Yasumizu Y; Fushimi A; Yamashita N; Hagiwara M; Zheng R; Wang J; Kui L; Singh H; Kharbanda S; Hu Q; Liu S; Kufe D
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427590
[TBL] [Abstract][Full Text] [Related]
11. MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer.
Yu B; You W; Chen G; Yu Y; Yang Q
Cell Cycle; 2019 Oct; 18(20):2641-2650. PubMed ID: 31411515
[TBL] [Abstract][Full Text] [Related]
12. MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.
Hata T; Rajabi H; Takahashi H; Yasumizu Y; Li W; Jin C; Long MD; Hu Q; Liu S; Fushimi A; Yamashita N; Kui L; Hong D; Yamamoto M; Miyo M; Hiraki M; Maeda T; Suzuki Y; Samur MK; Kufe D
Cancer Res; 2019 Nov; 79(22):5711-5722. PubMed ID: 31519689
[TBL] [Abstract][Full Text] [Related]
13. MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment.
Kufe DW
Carcinogenesis; 2020 Sep; 41(9):1173-1183. PubMed ID: 32710608
[TBL] [Abstract][Full Text] [Related]
14. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract][Full Text] [Related]
15. MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells.
Hagiwara M; Yasumizu Y; Yamashita N; Rajabi H; Fushimi A; Long MD; Li W; Bhattacharya A; Ahmad R; Oya M; Liu S; Kufe D
Cancer Res; 2021 Feb; 81(4):1111-1122. PubMed ID: 33323379
[TBL] [Abstract][Full Text] [Related]
16. MiR-4319 Suppress the Malignancy of Triple-Negative Breast Cancer by Regulating Self-Renewal and Tumorigenesis of Stem Cells.
Chu J; Li Y; Fan X; Ma J; Li J; Lu G; Zhang Y; Huang Y; Li W; Huang X; Fu Z; Yin Y; Yuan H
Cell Physiol Biochem; 2018; 48(2):593-604. PubMed ID: 30021199
[TBL] [Abstract][Full Text] [Related]
17. MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
Goode G; Gunda V; Chaika NV; Purohit V; Yu F; Singh PK
PLoS One; 2017; 12(5):e0176820. PubMed ID: 28464016
[TBL] [Abstract][Full Text] [Related]
18. Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells.
Kufe DW
J Cancer Metastasis Treat; 2022; 8():. PubMed ID: 35539431
[TBL] [Abstract][Full Text] [Related]
19. MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells.
Yamashita N; Withers H; Morimoto Y; Bhattacharya A; Haratake N; Daimon T; Fushimi A; Nakashoji A; Thorner AR; Isenhart E; Rosario S; Long MD; Kufe D
iScience; 2023 Nov; 26(11):108168. PubMed ID: 37915591
[TBL] [Abstract][Full Text] [Related]
20. Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
Doherty MR; Cheon H; Junk DJ; Vinayak S; Varadan V; Telli ML; Ford JM; Stark GR; Jackson MW
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13792-13797. PubMed ID: 29229854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]